Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis:: improvement by Insulin-like Growth Factor I -: art. no. 12

被引:35
作者
Castilla-Cortázar, I
Pascual, M
Urdaneta, E
Pardo, J
Puche, JE
Vivas, B
Díaz-Casares, A
García, M
Díaz-Sánchez, M
Varela-Nieto, I
Castilla, A
González-Barón, S
机构
[1] Univ Navarra, Clin Univ, Dept Physiol, Navarra, Spain
[2] Univ Navarra, Clin Univ, Dept Pathol, Navarra, Spain
[3] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain
[4] Univ Malaga, Sch Med, Dept Human Physiol, Malaga, Spain
[5] Hosp Sierrallana, Dept Internal Med, Tollelavega, Spain
[6] Univ Basque Country, Sch Med, Vitoria, Spain
关键词
D O I
10.1186/1471-230X-4-12
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Previous results have shown that in rats with non-ascitic cirrhosis there is an altered transport of sugars and amino acids associated with elongated microvilli. These alterations returned to normal with the administration of Insulin-Like Growth Factor-I (IGF-I). The aims of this study were to explore the evolution of these alterations and analyse the effect of IGF-I in rats with advanced cirrhosis and ascites. Thus, jejunal structure and nutrient transport (D-galactose, L-leucine, L-proline, L-glutamic acid and L-cystine) were studied in rats with ascitic cirrhosis. Methods: Advanced cirrhosis was induced by CCl4 inhalation and Phenobarbital administration for 30 weeks. Cirrhotic animals were divided into two groups which received IGF-I or saline during two weeks. Control group was studied in parallel. Jejunal microvilli were studied by electron microscopy. Nutrient transport was assessed in brush border membrane vesicles using C-14 or S-35-labelled subtracts in the three experimental groups. Results: Intestinal active Na+-dependent transport was significantly reduced in untreated cirrhotic rats. Kinetic studies showed a decreased V-max and a reduced affinity for sugar and four amino acids transporters ( expressed as an increased K-t) in the brush border membrane vesicles from untreated cirrhotic rats as compared with controls. Both parameters were normalised in the IGF-I-treated cirrhotic group. Electron microscopy showed elongation and fusion of microvilli with degenerative membrane lesions and/or notable atrophy. Conclusions: The initial microvilli elongation reported in non ascitic cirrhosis develops into atrophy in rats with advanced cirrhosis and nutrient transports (monosaccharides and amino acids) are progressively reduced. Both morphological and functional alterations improved significantly with low doses of IGF-I.
引用
收藏
页数:9
相关论文
共 34 条
[11]   INSULIN-LIKE GROWTH FACTOR-I - A GOOD INDICATOR OF FUNCTIONAL HEPATOCELLULAR CAPACITY IN ALCOHOLIC LIVER-CIRRHOSIS [J].
CAUFRIEZ, A ;
REDING, P ;
URBAIN, D ;
GOLSTEIN, J ;
COPINSCHI, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (04) :317-321
[12]   INSULIN-LIKE GROWTH-FACTOR-I IN HUMAN GASTROINTESTINAL EXOCRINE SECRETIONS [J].
CHAURASIA, OP ;
MARCUARD, SP ;
SEIDEL, ER .
REGULATORY PEPTIDES, 1994, 50 (02) :113-119
[13]   In vivo gluten ingestion in coeliac disease [J].
Ciclitira, PJ ;
Ellis, HJ .
DIGESTIVE DISEASES, 1998, 16 (06) :337-340
[14]   BODY-COMPOSITION IN NONALCOHOLIC CIRRHOSIS - THE EFFECT OF DISEASE ETIOLOGY AND SEVERITY ON NUTRITIONAL COMPARTMENTS [J].
CRAWFORD, DHG ;
SHEPHERD, RW ;
HALLIDAY, JW ;
COOKSLEY, GWGE ;
GOLDING, SD ;
CHENG, WSC ;
POWELL, LW .
GASTROENTEROLOGY, 1994, 106 (06) :1611-1617
[15]  
DONAGHY A, 1995, HEPATOLOGY, V21, P680, DOI 10.1016/0270-9139(95)90518-9
[16]  
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
[17]   Influence of fibroblast growth factor (bFGF) and insulin like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture [J].
Harder, BA ;
Schaub, MC ;
Eppenberger, HM ;
EppenbergerEberhardt, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (01) :19-31
[18]   SERUM GROWTH HORMONE-BINDING PROTEIN, INSULIN-LIKE GROWTH FACTOR-I, AND GROWTH-HORMONE IN PATIENTS WITH LIVER-CIRRHOSIS [J].
HATTORI, N ;
KURAHACHI, H ;
IKEKUBO, K ;
ISHIHARA, T ;
MORIDERA, K ;
HINO, M ;
SAIKI, Y ;
IMURA, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (04) :377-381
[19]  
HOPFER U, 1973, J BIOL CHEM, V248, P25
[20]  
KONDRUP J, 1992, EUR J CLIN NUTR, V46, P239